Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS

Aragon Pharmaceuticals, Inc. · 2015
ClinicalTrials.gov · Datasets · License: Public Domain · 2015
Open Source ↗
prostate-cancerradiation
prostatic neoplasms, prostate cancer, high-risk prostate cancer, jnj-56021927, apalutamide, atlas, radiation, long-term hormone therapy, localized or locally advanced prostate cancer, janssen, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 869617
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.